Here, our results indicated that a B7x neutralizing antibody sensitized colorectal tumors to HDAC inhibitor treatment in vivo, and the combination of B7x neutralizing antibody and HDAC inhibitor showed enhanced suppression of metastasis in a mouse lung metastatic model. The gene discussed is VTCN1; the disease is colorectal neoplasm.